Mixed chimerism and transplantation tolerance

被引:123
作者
Wekerle, T
Sykes, M
机构
[1] Univ Vienna, Vienna Gen Hosp, Dept Surg, A-1090 Vienna, Austria
[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med, BMT Sect,Transplantat Biol Res Ctr, Boston, MA 02129 USA
来源
ANNUAL REVIEW OF MEDICINE | 2001年 / 52卷
关键词
macrochimerism; organ transplantation; bone marrow transplantation; costimulatory blockade; xenotransplantation;
D O I
10.1146/annurev.med.52.1.353
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Achieving transplanatation tolerance is an important goal in the effort to reduce long-term morbidity and mortality in organ transplant recipients. Robust, lifelong, donor-specific tolerance can be reliably achieved by induction of mixed chimerism in various animal models. To date. the clinical application of these protocols has been impeded partly by the potential toxicity of the required host conditioning regimens and the lack of successful studies in large animals. This article reviews the progress achieved in recent years in developing considerably milder conditioning protocols in rodents, and in extending some of these models to achieve permanent mixed chimerism and tolerance in large animals. Advances in the induction of xenogeneic tolerance through mixed chimerism are also discussed.
引用
收藏
页码:353 / +
页数:19
相关论文
共 106 条
[31]  
HELG C, 1994, TRANSPLANTATION, V58, P1420
[32]   In vivo T cell depletion in miniature swine using the swine CD3 immunotoxin, pCD3-CRM9 [J].
Huang, CA ;
Yamada, K ;
Murphy, MC ;
Shimizu, A ;
Colvin, RB ;
Neville, DM ;
Sachs, DH .
TRANSPLANTATION, 1999, 68 (06) :855-860
[33]   Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model [J].
Huang, CA ;
Fuchimoto, Y ;
Scheier-Dolberg, R ;
Murphy, MC ;
Neville, DM ;
Sachs, DH .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (02) :173-181
[34]  
ILDSTAD ST, 1986, J IMMUNOL, V136, P28
[35]   CHARACTERIZATION OF MIXED ALLOGENEIC CHIMERAS - IMMUNOCOMPETENCE, INVITRO REACTIVITY, AND GENETIC SPECIFICITY OF TOLERANCE [J].
ILDSTAD, ST ;
WREN, SM ;
BLUESTONE, JA ;
BARBIERI, SA ;
SACHS, DH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 162 (01) :231-244
[36]   RECONSTITUTION WITH SYNGENEIC PLUS ALLOGENEIC OR XENOGENEIC BONE-MARROW LEADS TO SPECIFIC ACCEPTANCE OF ALLOGRAFTS OR XENOGRAFTS [J].
ILDSTAD, ST ;
SACHS, DH .
NATURE, 1984, 307 (5947) :168-170
[37]   DISTINCT MECHANISMS OF NEONATAL TOLERANCE INDUCED BY DENDRITIC CELLS AND THYMIC B-CELLS [J].
INABA, M ;
INABA, K ;
HOSONO, M ;
KUMAMOTO, T ;
ISHIDA, T ;
MURAMATSU, S ;
MASUDA, T ;
IKEHARA, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (03) :549-559
[38]   TOLERANCE TO AN HLA-B,DR DISPARATE KIDNEY ALLOGRAFT AFTER BONE-MARROW TRANSPLANTATION FROM SAME DONOR [J].
JACOBSEN, N ;
TAANING, E ;
LADEFOGED, J ;
KRISTENSEN, JK ;
PEDERSEN, FK .
LANCET, 1994, 343 (8900) :800-800
[39]  
Kawai T, 2000, TRANSPLANTATION, V69, pS370
[40]   MIXED ALLOGENEIC CHIMERISM AND RENAL-ALLOGRAFT TOLERANCE IN CYNOMOLGUS MONKEYS [J].
KAWAI, T ;
COSIMI, AB ;
COLVIN, RB ;
POWELSON, J ;
EASON, J ;
KOZLOWSKI, T ;
SYKES, M ;
MONROY, R ;
TANAKA, M ;
SACHS, DH .
TRANSPLANTATION, 1995, 59 (02) :256-262